Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.87 USD 0.34% Market Closed
Market Cap: 337.5m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kamada Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Long-Term Debt
$9.6m
CAGR 3-Years
43%
CAGR 5-Years
16%
CAGR 10-Years
2%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Long-Term Debt
$7.2m
CAGR 3-Years
27%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Long-Term Debt
$121.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Long-Term Debt
â‚Ş9.1m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Kamada Ltd
Glance View

Market Cap
337.4m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.35 USD
Overvaluation 9%
Intrinsic Value
Price

See Also

What is Kamada Ltd's Long-Term Debt?
Long-Term Debt
9.6m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Long-Term Debt amounts to 9.6m USD.

What is Kamada Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
2%

Over the last year, the Long-Term Debt growth was 104%. The average annual Long-Term Debt growth rates for Kamada Ltd have been 43% over the past three years , 16% over the past five years , and 2% over the past ten years .

Back to Top